UiPath Inc
F:9UV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
UiPath Inc
F:9UV
|
US |
|
T
|
Tenet Healthcare Corp
SWB:THC1
|
US |
|
S
|
Stora Enso Oyj
XMUN:ENUA
|
FI |
|
I
|
ITV PLC
OTC:ITVPY
|
UK |
|
S
|
Seven & i Holdings Co Ltd
XMUN:S6M
|
JP |
|
thyssenkrupp AG
F:TKA
|
DE |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9UV's stock price target?
Price Target
16.279
EUR
According to Wall Street analysts, the average 1-year price target for 
9UV is 16.279 EUR with a low forecast of 10.727 EUR and a high forecast of 23.36 EUR.
What is the Revenue forecast for UiPath Inc?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Revenue has been 30%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for UiPath Inc?
Projected CAGR
9%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 30%. The projected CAGR for the next 3 years is 9%.
What is the Operating Income forecast for UiPath Inc?
Projected CAGR
110%
The compound annual growth rate for Operating Income over the next 3 years is 110%.
What is the Pre-Tax Income forecast for UiPath Inc?
Projected CAGR
84%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 84%.
What is the Net Income forecast for UiPath Inc?
Projected CAGR
26%
The compound annual growth rate for Net Income over the next 3 years is 26%.